Molecule Details
| InChIKey | FFCQFLOKIRUZOS-UHFFFAOYSA-N |
|---|---|
| Compound Name | 5-[3-(4-Isoquinolin-6-ylpiperazin-1-yl)-3-oxopropyl]-5-phenylimidazolidine-2,4-dione |
| Canonical SMILES | O=C1NC(=O)C(CCC(=O)N2CCN(c3ccc4cnccc4c3)CC2)(c2ccccc2)N1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.64 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
Target Activities (3)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P08253 | MMP2 | Homo sapiens | Human | PF00040 PF00045 PF00413 | 7.4 | IC50 | ChEMBL;BindingDB |
| P45452 | MMP13 | Homo sapiens | Human | PF00045 PF00413 PF01471 | 6.4 | IC50 | ChEMBL;BindingDB |
| Q9UNA0 | ADAMTS5 | Homo sapiens | Human | PF17771 PF19236 PF05986 PF01421 PF19030 PF00090 | 6.0 | IC50 | ChEMBL;BindingDB |